当前位置: 首页 > 期刊 > 《上海医药》 > 2018年第7期
编号:13236311
生物标志物用于肺癌早期诊断的研究进展(4)
http://www.100md.com 2018年3月5日 《上海医药》 2018年第7期
     [17] 陳璐, 刘畅, 康涛, 等. 呼出气体中部分可挥发性有机物用于诊断肺癌的预测模型[J]. 肿瘤, 2015, 35(4): 404-413.

    [18] Bajtarevic A, Ager C, Pienz M, et al. Noninvasive detection of lung cancer by analysis of exhaled breath [J/OL]. BMC Cancer, 2009, 9: 348 [2018-03-25]. doi: 10.1186/1471-2407-9-348.

    [19] Gessner C, Kuhn H, Toepfer K, et al. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients [J]. Lung Cancer, 2004, 43(2): 215-222.

    [20] Carpagnano GE, Foschino-Barbaro MP, Mulé G, et al. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer [J]. Am J Respir Crit Care Med, 2005, 172(6): 738-744.

    [21] Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, et al. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer [J]. Lung Cancer, 2009, 64(2): 219-225.

    [22] Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath [J]. Am J Respir Crit Care Med, 2005, 171(11): 1286-1291., http://www.100md.com(张龙富 张新)
上一页1 2 3 4